Skip to main content

Clinical Pharmacokinetics

Ausgabe 5/2020

Inhalt (10 Artikel)

Open Access Review Article

Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication

Mohamed-Eslam F. Mohamed, Ben Klünder, Ahmed A. Othman

Original Research Article

Exposure–Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis

Ahmed A. Suleiman, Amit Khatri, Rajneet K. Oberoi, Ahmed A. Othman

Open Access Original Research Article

A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement

Louise M. Andrews, Brenda C. M. de Winter, Elisabeth A. M. Cornelissen, Huib de Jong, Dennis A. Hesselink, Michiel F. Schreuder, Roger J. M. Brüggemann, Teun van Gelder, Karlien Cransberg

Open Access Original Research Article

Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach

Alexander Solms, Alfonso Iorio, Maurice J. Ahsman, Peter Vis, Anita Shah, Erik Berntorp, Dirk Garmann

Original Research Article

Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Blood Components and Binding Proteins

Khaled Abduljalil, Masoud Jamei, Trevor N. Johnson

Original Research Article

Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents

Christina Gade, Eva Sverrisdóttir, Kim Dalhoff, Jesper Sonne, Mia Østergaard Johansen, Hanne Rolighed Christensen, Jürgen Burhenne, Gerd Mikus, Jens Christian Holm, Trine Meldgaard Lund, Helle Holst

Letter to the Editor

Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”

Rudolf Hoermann, John E. M. Midgley, Rolf Larisch, Johannes W. Dietrich